000 01821 a2200457 4500
005 20250517114235.0
264 0 _c20171031
008 201710s 0 0 eng d
022 _a1463-1326
024 7 _a10.1111/dom.12731
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShirakawa, J
245 0 0 _aNovel factors modulating human β-cell proliferation.
_h[electronic resource]
260 _bDiabetes, obesity & metabolism
_c09 2016
300 _a71-7 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdaptor Proteins, Signal Transducing
_xantagonists & inhibitors
650 0 4 _aAnimals
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aDenosumab
_xpharmacology
650 0 4 _aDiabetes Mellitus
_xdrug therapy
650 0 4 _aGlycogen Synthase Kinase 3 beta
_xantagonists & inhibitors
650 0 4 _aHarmine
_xpharmacology
650 0 4 _aHumans
650 0 4 _aI-kappa B Kinase
_xantagonists & inhibitors
650 0 4 _aInsulin-Secreting Cells
_xcytology
650 0 4 _aMonoamine Oxidase Inhibitors
_xpharmacology
650 0 4 _aOsteoprotegerin
_xpharmacology
650 0 4 _aPhenylurea Compounds
_xpharmacology
650 0 4 _aProtein Serine-Threonine Kinases
_xantagonists & inhibitors
650 0 4 _aProtein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aRNA-Binding Proteins
_xantagonists & inhibitors
650 0 4 _aReceptor Activator of Nuclear Factor-kappa B
_xantagonists & inhibitors
650 0 4 _aSerine Proteinase Inhibitors
_xpharmacology
650 0 4 _aSerpins
_xpharmacology
650 0 4 _aTryptamines
_xpharmacology
650 0 4 _aDyrk Kinases
700 1 _aKulkarni, R N
773 0 _tDiabetes, obesity & metabolism
_gvol. 18 Suppl 1
_gp. 71-7
856 4 0 _uhttps://doi.org/10.1111/dom.12731
_zAvailable from publisher's website
999 _c26407377
_d26407377